Genetic Variability of Antioxidative Mechanisms and Cardiotoxicity after Adjuvant Radiotherapy in HER2-Positive Breast Cancer Patients

<div>The association of <i>PON1</i> rs854560 (a) and <i>PON1</i> rs662 (b) polymorphisms with N-terminal pro B-type natriuretic peptide (NT-proBNP) levels after adjuvant radiotherapy in HER2-positive breast cancer patients.</div>

Disease Markers

fig1

Figure 1

Figure 1: Genetic Variability of Antioxidative Mechanisms and Cardiotoxicity after Adjuvant Radiotherapy in HER2-Positive Breast Cancer Patients 